Autek China Inc. (SHE:300595)
16.50
+0.43 (2.68%)
Jan 23, 2026, 3:04 PM CST
Autek China Revenue
Autek China had revenue of 562.10M CNY in the quarter ending September 30, 2025, with 2.62% growth. This brings the company's revenue in the last twelve months to 1.82B, down -1.80% year-over-year. In the year 2024, Autek China had annual revenue of 1.81B with 4.40% growth.
Revenue (ttm)
1.82B
Revenue Growth
-1.80%
P/S Ratio
8.14
Revenue / Employee
507.10K
Employees
3,580
Market Cap
14.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.81B | 76.44M | 4.40% |
| Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
| Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
| Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
| Dec 31, 2020 | 870.66M | 223.76M | 34.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Winner Medical | 10.80B |
| Tofflon Science and Technology Group | 5.22B |
| Zhende Medical | 4.32B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.12B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Sansure Biotech | 1.67B |
| Andon Health | 1.57B |
| Eyebright Medical Technology (Beijing) | 1.48B |